HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

AbstractINTRODUCTION:
Triggering receptor expressed on myeloid cells (TREM) receptors and TREM-like transcript (TLT; or TREML) receptors of the immunoglobulin superfamily are known as key modulators of host immune responses. TREM-1 (CD354) and TREM-2 share the transmembrane adaptor DNAX-activation protein of 12 kDa (DAP12), but they possess separate stimulatory and inhibitory functional roles, especially in myeloid cells.
AREAS COVERED:
This review covers findings related to TREMs and TLTs published in patent applications from their discovery in 2000 to the present. New roles for TREM-1, TREM-2, TLT-1 and TLT-2 in maladies ranging from acute and chronic inflammatory disorders to cardiovascular diseases and cancers are discussed. Putative endogenous ligands and novel synthetic peptide blockers are also discussed.
EXPERT OPINION:
So far, therapeutic use of activators/blockers specific for TREMs and TLTs has been limited to preclinical animal models. TREM-1 is an immediate therapeutic target for acute and chronic inflammatory conditions, especially sepsis. Certain mutations in DAP12 and TREM-2 manifest into a disorder named polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, and newly identified TREM-2 variants confer a significant increase in risk of developing Alzheimer's disease. This makes TREM-2 an attractive therapeutic target for neurodegenerative diseases.
AuthorsChristopher J Pelham, Amit N Pandya, Devendra K Agrawal
JournalExpert opinion on therapeutic patents (Expert Opin Ther Pat) Vol. 24 Issue 12 Pg. 1383-95 (Dec 2014) ISSN: 1744-7674 [Electronic] England
PMID25363248 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM-2a receptor
  • TREM-2b receptor
  • TREM1 protein, human
  • TREML1 protein, human
  • TREML4 protein, human
  • Trem3 protein, mouse
  • Triggering Receptor Expressed on Myeloid Cells-1
Topics
  • Animals
  • Humans
  • Membrane Glycoproteins (drug effects, physiology)
  • Patents as Topic
  • Receptors, Immunologic (drug effects, physiology)
  • Triggering Receptor Expressed on Myeloid Cells-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: